Kerim K. Aksoy
Lawyers
Filters
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
Kenvue $7.75 billion senior notes offering
The investment-grade offering comprises eight tranches of notes
TD SYNNEX $502 million secondary offering
The shares are listed on the NYSE